litlas
Log inCreate account

Eliav Barr

Active 1991–2022

53
Papers
19,033
Citations
51
h-index
53
i10-index

Citations

Citations per year for Eliav Barr1992: 5 citations1993: 20 citations1994: 16 citations1995: 16 citations1996: 32 citations1997: 40 citations1998: 23 citations1999: 21 citations2000: 19 citations2001: 17 citations2002: 30 citations2003: 64 citations2004: 100 citations2005: 127 citations2006: 212 citations2007: 261 citations2008: 191 citations2009: 220 citations2010: 205 citations2011: 194 citations2012: 182 citations2013: 152 citations2014: 125 citations2015: 181 citations2016: 171 citations2017: 139 citations2018: 135 citations2019: 363 citations2020: 276 citations2021: 228 citations2022: 150 citations2023: 117 citations2024: 143 citations2025: 87 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,511 citing papers, 31.3% of this breakdownUnited Kingdom: 323 citing papers, 6.7% of this breakdownCanada: 247 citing papers, 5.1% of this breakdownAustralia: 215 citing papers, 4.4% of this breakdownFrance: 192 citing papers, 4% of this breakdownGermany: 177 citing papers, 3.7% of this breakdownItaly: 152 citing papers, 3.1% of this breakdownBelgium: 133 citing papers, 2.7% of this breakdownSpain: 132 citing papers, 2.7% of this breakdownChina: 129 citing papers, 2.7% of this breakdownNetherlands: 115 citing papers, 2.4% of this breakdownSweden: 87 citing papers, 1.8% of this breakdown
0%31.3%Other 29.4%

Institutions

Fields

  • Medicine81.6%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology4.4%
  • Social Sciences1.8%
  • Environmental Science0.6%
  • Health Professions0.5%
  • Other2.9%

Topics

  • Cervical Cancer and HPV Research16.5%
  • Hepatitis B Virus Studies7.2%
  • Hepatitis C virus research4.3%
  • Genital Health and Disease4.3%
  • Head and Neck Cancer Studies3.8%
  • Vaccine Coverage and Hesitancy3.8%
  • Other60.1%

Coauthors

All papers

Open in search
  1. Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

    Authors: Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone, Edson Duarte Moreira, Mary E. Penny, Carlos Aranda, Eftyhia Vardas, Harald Moi, Heiko Jessen, Richard J. Hillman, Yen-Hwa Chang, Daron Ferris, Danielle Rouleau, Janine T. Bryan, J. Brooke Marshall, Scott Vuocolo, Eliav Barr, David Radley, Richard M. Haupt, Dalya Güriş - New England Journal of Medicine 2011 cited by 1,141

  2. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

    Authors: Suzanne M. Garland, Mauricio Hernández‐Ávila, Cosette M. Wheeler, Gonzalo Pérez, Diane M. Harper, Sepp Leodolter, Grace Tang, Daron G. Ferris, Marc Steben, Janine T. Bryan, Frank J. Taddeo, Radha Railkar, Mark T. Esser, Heather L. Sings, Micki Nelson, John W. Boslego, Carlos Sattler, Eliav Barr, Laura A. Koutsky - New England Journal of Medicine 2007 cited by 1,899

  3. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES

    Authors: Jon S. Abramson, Larry Pickering, Janet R. Gilsdorf, Eileen M. Dunne, Herschel W. Lawson, Gary Dubin, Eliav Barr, Harrell W. Chesson, Geoff P. Garnett, Lauri E. Markowitz - 2006 cited by 940

  4. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Authors: Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Kevin A. Ault, Anna R. Giuliano, Cosette M. Wheeler, Laura A. Koutsky, Christian Malm, Matti Lehtinen, Finn Egil Skjeldestad, Sven-Eric Olsson, Margareta Steinwall, Darron R. Brown, Robert J. Kurman, Brigitte M. Ronnett, Mark H. Stoler, Alex Ferenczy, Diane M. Harper, Gretchen Tamms, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Frank J. Taddeo, Kathrin U. Jansen, Mark T. Esser, Heather L. Sings, Alfred J. Saah, Eliav Barr - The Lancet Oncology 2005 cited by 1,580

  5. Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

    Authors: Suzanne M. Garland, Marc Steben, Heather L. Sings, Margaret K. James, Shuang Lu, Radha Railkar, Eliav Barr, Richard M. Haupt, Elmar A. Joura - The Journal of Infectious Diseases 2009 cited by 531

  6. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

    Authors: Elmar A. Joura, Sepp Leodolter, Mauricio Hernández‐Ávila, Cosette M. Wheeler, Gonzalo Pérez, Laura A. Koutsky, Suzanne M. Garland, Diane M. Harper, Grace Tang, Daron G. Ferris, Marc Steben, Ronald W. Jones, Janine T. Bryan, Frank J. Taddeo, Oliver Bautista, Mark T. Esser, Heather L. Sings, Micki Nelson, John W. Boslego, Carlos Sattler, Eliav Barr, Jorma Paavonen - The Lancet 2007 cited by 580

  7. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

    Authors: Nubia Muñóz, Ricardo Manalastas, Punee Pitisuttithum, Damrong Tresukosol, Joseph Monsonégo, Kevin A. Ault, Christine Clavel, Joaquín Luna, Evan R. Myers, Sara Hood, Oliver Bautista, Janine T. Bryan, Frank J. Taddeo, Mark T. Esser, Scott Vuocolo, Richard M. Haupt, Eliav Barr, Alfred J. Saah - The Lancet 2009 cited by 480

  8. Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

    Authors: Jason Grebely, Gregory J. Dore, Frederick L. Altice, Brian Conway, Alain H. Litwin, Brianna L. Norton, Olav Dalgård, Edward Gane, Oren Shibolet, Ronald Nahass, Anne F. Luetkemeyer, Cheng‐Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M. Kelly, Peggy Hwang, Ernest Asante‐Appiah, Barbara Haber, Eliav Barr, Michael Robertson, Heather Platt - Annals of Internal Medicine 2022 cited by 19

  9. A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

    Authors: Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler, Darron R. Brown, Eliav Barr, Frances B. Alvarez, Lisa M. Chiacchierini, Kathrin U. Jansen - New England Journal of Medicine 2002 cited by 1,608

  10. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

    Authors: Darron R. Brown, Susanne K. Kjær, Kristján Sigurðsson, Ole‐Erik Iversen, Mauricio Hernández-Ávila, Cosette M. Wheeler, Gonzalo Pérez, Laura A. Koutsky, Eng Hseon Tay, Patricia García, Kevin A. Ault, Suzanne M. Garland, Sepp Leodolter, Sven‐Eric Olsson, Grace Tang, Daron G. Ferris, Jorma Paavonen, Marc Steben, F. Xavier Bosch, Joakim Dillner, Elmar A. Joura, Robert J. Kurman, Sławomir Majewski, Nubia Muñóz, Evan R. Myers, Luisa L. Villa, Frank J. Taddeo, Christine C. Roberts, Amha Tadesse, Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 cited by 627

  11. Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

    Authors: Gregory J. Dore, Frederick L. Altice, Alain H. Litwin, Olav Dalgård, Edward Gane, Oren Shibolet, Anne F. Luetkemeyer, Ronald Nahass, Cheng‐Yuan Peng, Brian Conway, Jason Grebely, Anita Y. M. Howe, Isaias Noel Gendrano, Erluo Chen, Hsueh‐Cheng Huang, Frank J. Dutko, David C. Nickle, Bach‐Yen Nguyen, Janice Wahl, Eliav Barr, Michael Robertson, Heather Platt, on behalf of the C-EDGE CO-STAR Study Group - Annals of Internal Medicine 2016 cited by 363

  12. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    Authors: Nubia Muñóz, Susanne K. Kjær, Kristján Sigurðsson, Ole‐Erik Iversen, Mauricio Hernández‐Ávila, Cosette M. Wheeler, Gonzalo Pérez, Darron R. Brown, Laura A. Koutsky, Eng Hseon Tay, Patricia García, Kevin A. Ault, Suzanne M. Garland, Sepp Leodolter, Sven‐Eric Olsson, Grace Tang, Daron G. Ferris, Jorma Paavonen, Marc Steben, F. Xavier Bosch, Joakim Dillner, Warner K. Huh, Elmar A. Joura, Robert J. Kurman, Sławomir Majewski, Evan R. Myers, Luisa L. Villa, Frank J. Taddeo, Christine C. Roberts, Amha Tadesse, Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr, Richard M. Haupt - JNCI Journal of the National Cancer Institute 2010 cited by 564

  13. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Authors: Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Darron R. Brown, Alex Ferenczy, Diane M. Harper, Laura A. Koutsky, Robert J. Kurman, Matti Lehtinen, Christian Malm, Sven-Eric Olsson, Brigitte M. Ronnett, Finn Egil Skjeldestad, Margareta Steinwall, Mark H. Stoler, Cosette M. Wheeler, Frank J. Taddeo, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Rocio D. Marchese, Mark T. Esser, Janine T. Bryan, Kathrin U. Jansen, Heather L. Sings, Gretchen Tamms, Alfred J. Saah, Eliav Barr - Vaccine 2006 cited by 469

  14. A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    Authors: Susanne K. Kjær, Kristján Sigurðsson, Ole‐Erik Iversen, Mauricio Hernández‐Ávila, Cosette M. Wheeler, Gonzalo Pérez, Darron R. Brown, Laura A. Koutsky, Eng Hseon Tay, Patricia García, Kevin A. Ault, Suzanne M. Garland, Sepp Leodolter, Sven‐Eric Olsson, Grace Tang, Daron G. Ferris, Jorma Paavonen, Matti Lehtinen, Marc Steben, F. Xavier Bosch, Joakim Dillner, Elmar A. Joura, Sławomir Majewski, Nubia Muñóz, Evan R. Myers, Luisa L. Villa, Frank J. Taddeo, Christine C. Roberts, Amha Tadesse, Janine T. Bryan, Roger Maansson, Shuang Lu, Scott Vuocolo, Teresa M. Hesley, Alfred J. Saah, Eliav Barr, Richard M. Haupt - Cancer Prevention Research 2009 cited by 328

  15. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

    Authors: Cosette M. Wheeler, Susanne K. Kjær, Kristján Sigurðsson, Ole‐Erik Iversen, Mauricio Hernández-Ávila, Gonzalo Pérez, Darron R. Brown, Laura A. Koutsky, Eng Hseon Tay, Patricia García, Kevin A. Ault, Suzanne M. Garland, Sepp Leodolter, Sven‐Eric Olsson, Grace Tang, Daron G. Ferris, Jorma Paavonen, Marc Steben, F. Xavier Bosch, Joakim Dillner, Elmar A. Joura, Robert J. Kurman, Sławomir Majewski, Nubia Muñóz, Evan R. Myers, Luisa L. Villa, Frank J. Taddeo, Christine C. Roberts, Amha Tadesse, Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Margaret K. James, Scott Vuocolo, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 cited by 242

  16. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Authors: Sven‐Eric Olsson, Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Christian Malm, Ole‐Erik Iversen, John Høye, Margareta Steinwall, Grete Riis-Johannessen, Agneta Andersson‐Ellström, Kristina Elfgren, Geo von Krogh, Matti Lehtinen, Jorma Paavonen, Gretchen Tamms, Katherine Giacoletti, Lisa Lupinacci, Mark T. Esser, Scott Vuocolo, Alfred J. Saah, Eliav Barr - Vaccine 2007 cited by 456

  17. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

    Authors: David Roth, David R. Nelson, Annette Bruchfeld, AnnMarie Liapakis, Marcelo Silva, Howard Monsour, Paul Martin, Stanislas Pol, María‐Carlota Londoño, Tarek Hassanein, Philippe J. Zamor, Eli Zuckerman, Shuyan Wan, Beth Jackson, Bach-Yen Nguyen, Michael Robertson, Eliav Barr, Janice Wahl, Wayne Greaves - The Lancet 2015 cited by 666

  18. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

    Authors: Elmar A. Joura, Susanne K. Kjær, Cosette M. Wheeler, Kristján Sigurðsson, Ole-Erik Iversen, Mauricio Hernández‐Ávila, Gonzalo Pérez, Darron R. Brown, Laura A. Koutsky, Eng Hseon Tay, Patricia García, Kevin A. Ault, Suzanne M. Garland, Sepp Leodolter, Sven-Eric Olsson, Grace Tang, Daron G. Ferris, Jorma Paavonen, Matti Lehtinen, Marc Steben, Xavier Bosch, Joakim Dillner, Robert J. Kurman, Sławomir Majewski, Nubia Muñóz, Evan R. Myers, Luisa L. Villa, Frank J. Taddeo, Christine C. Roberts, Amha Tadesse, Janine T. Bryan, Lisa Lupinacci, Katherine Giacoletti, Shuang Lu, Scott Vuocolo, Teresa M. Hesley, Richard M. Haupt, Eliav Barr - Vaccine 2008 cited by 196

  19. Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

    Authors: Stefan Zeuzem, Reem Ghalib, K. Rajender Reddy, Paul J. Pockros, Ziv Ben Ari, Yue Zhao, Deborah D. Brown, Shuyan Wan, Mark J. DiNubile, Bach‐Yen Nguyen, Michael Robertson, Janice Wahl, Eliav Barr, Joan R. Butterton - Annals of Internal Medicine 2015 cited by 517

  20. Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

    Authors: Stan L. Block, Terry Nolan, Carlos Sattler, Eliav Barr, Katherine Giacoletti, Colin D. Marchant, Xavier Castellsagué, Steven A. Rusche, Suzanne Lukac, Janine T. Bryan, Paul F. Cavanaugh, Keith S. Reisinger, for the Protocol 016 Study Group - PEDIATRICS 2006 cited by 485

  21. Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

    Authors: Constance Mao, Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler, Darron R. Brown, Dorothy J. Wiley, Frances B. Alvarez, Oliver Bautista, Kathrin U. Jansen, Eliav Barr - Obstetrics and Gynecology 2006 cited by 453

  22. Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions

    Authors: Judith F. Smith, Michelle Brownlow, Martha Brown, Rose Kowalski, Mark T. Esser, Wanda Ruiz, Eliav Barr, Darron R. Brown, Janine T. Bryan - Human Vaccines 2007 cited by 136

  23. Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus‐Like‐Particle Vaccine

    Authors: Anna R. Giuliano, Eduardo Lazcano‐Ponce, Luisa L. Villa, Terry Nolan, Colin D. Marchant, David Radley, Greg Golm, Kathleen McCarroll, Jimmy Yu, Mark T. Esser, Scott Vuocolo, Eliav Barr - The Journal of Infectious Diseases 2007 cited by 120

  24. Longitudinal Evaluation of Interobserver and Intraobserver Agreement of Cervical Intraepithelial Neoplasia Diagnosis Among an Experienced Panel of Gynecologic Pathologists

    Authors: Bing Cai, Brigitte M. Ronnett, Mark H. Stoler, Alex Ferenczy, Robert J. Kurman, David J. Sadow, Fran Alvarez, J Matthew Pearson, Heather L. Sings, Eliav Barr, Kai‐Li Liaw - The American Journal of Surgical Pathology 2007 cited by 58